95% CI, 0.42-2.16)
Late last year, the company halted development of a twice-daily version of danuglipron after high rates of nausea and vomiting led patients to drop out of a mid-stage study of about 1,400 people
This comparison breaks down how retatrutide and tirzepatide differ, what current clinical data shows, and which type of patient each may be better suited for
Despite its therapeutic potential, current evidence is limited by methodological gaps, preclinical inconsistencies and weak clinical evidence (no large-scale randomized controlled trials [RCTs])
Researchers are unsure of the exact process of how BPC-157 facilitates healing, but real-time PCR, Western Blot Analysis, and MTT assay showed increased healing and growth in tendon fibroblasts of rats treated with BPC-157
Refrigeration is recommended and will ensure maximum potency and shelf life